Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsRent ExpenseShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Acadia Healthcare Company (ACHC) Short-Term Debt issuances (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Short-Term Debt issuances for 9 consecutive years, with $85.0 million as the latest value for Q1 2026.

  • For Q1 2026, Short-Term Debt issuances fell 88.82% year-over-year to $85.0 million; the TTM value through Mar 2026 reached -$560.0 million, down 161.88%, while the annual FY2025 figure was $115.0 million, 62.3% down from the prior year.
  • Short-Term Debt issuances hit $85.0 million in Q1 2026 for Acadia Healthcare Company, up from -$760.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $760.0 million in Q1 2025 and bottomed at -$760.0 million in Q4 2025.
  • Average Short-Term Debt issuances over 4 years is $60.6 million, with a median of $85.0 million recorded in 2026.
  • On a YoY basis, Short-Term Debt issuances climbed as much as 1420.0% in 2025 and fell as far as 900.0% in 2025.
  • Acadia Healthcare Company's Short-Term Debt issuances stood at $40.0 million in 2023, then soared by 137.5% to $95.0 million in 2024, then tumbled by 900.0% to -$760.0 million in 2025, then soared by 111.18% to $85.0 million in 2026.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at $85.0 million, -$760.0 million, and $760.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.